Patents Assigned to Antares Pharma, Inc.
  • Publication number: 20240131035
    Abstract: Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.
    Type: Application
    Filed: October 27, 2023
    Publication date: April 25, 2024
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming CHEN, Shaowei ONG
  • Publication number: 20240131275
    Abstract: An injection device for injecting medicament in a patient includes a syringe coupled to a housing and radially retained by a retaining rib. A needle guard is slideably coupled to the housing and spring biased in a distal direction by a return spring. A ram is slideably coupled to the housing and spring biased in the distal direction by a main spring. An initial position is defined by a retaining arm being disposed in the longitudinal path of the ram preventing firing. A released position is defined by the retaining arm being clear from the longitudinal path of the ram allowing the ram to extend distally. A locked position is defined by the retaining arm being disposed in the longitudinal path of the ram and a lock arm of the ram being disposed in the longitudinal path of the needle guard preventing the needle guard from being retracted.
    Type: Application
    Filed: December 11, 2023
    Publication date: April 25, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: John Pierre Mehawej, Bryan James Sarkinen
  • Publication number: 20240091239
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 21, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Publication number: 20240075209
    Abstract: In one embodiment there is an injector comprising a housing having a proximal end and a distal end, a shell, a plunger, a needle guard, a first member, and an actuation assembly. The shell may be within the housing and may have a cavity to receive at least a portion of a medicament chamber. The shell may be moveable with respect to the housing from an initial position to an injecting position. The plunger may be moveable with respect to the shell. The needle guard may be moveable between an extended position and a retracted position. The first member may be within the housing. The actuation assembly may be coupled to the housing and the shell. The needle guard may move the first member with respect to the housing as the needle guard moves from the extended position to the retracted position. The actuation assembly may move the shell from the initial position to the injecting position when the first member moves with respect to the housing.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 7, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: Kevin Swanson, Aaron V. Hua
  • Publication number: 20240024582
    Abstract: An injector includes a trigger mechanism including: a trigger member disposed about an axis having an aperture and a protrusion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a trigger engagement member configured to engage the aperture of the trigger member when the trigger member is in a pre-firing condition; an energy source associated with the ram for powering the ram to expel the medicament; and a user-operable firing-initiation member having an aperture engaged with the protrusion of the trigger member and operable for causing an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
    Type: Application
    Filed: October 4, 2023
    Publication date: January 25, 2024
    Applicant: Antares Pharma, Inc.
    Inventor: Michael Travanty
  • Patent number: 11878156
    Abstract: An injection device for injecting medicament in a patient includes a syringe coupled to a housing and radially retained by a retaining rib. A needle guard is slideably coupled to the housing and spring biased in a distal direction by a return spring. A ram is slideably coupled to the housing and spring biased in the distal direction by a main spring. An initial position is defined by a retaining arm being disposed in the longitudinal path of the ram preventing firing. A released position is defined by the retaining arm being clear from the longitudinal path of the ram allowing the ram to extend distally. A locked position is defined by the retaining arm being disposed in the longitudinal path of the ram and a lock arm of the ram being disposed in the longitudinal path of the needle guard preventing the needle guard from being retracted.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: January 23, 2024
    Assignee: ANTARES PHARMA, INC.
    Inventors: John Pierre Mehawej, Bryan James Sarkinen
  • Patent number: 11857555
    Abstract: Aqueous hydrocortisone sodium phosphate and monothioglycerol formulations are disclosed.
    Type: Grant
    Filed: November 18, 2022
    Date of Patent: January 2, 2024
    Assignee: ANTARES PHARMA, INC.
    Inventors: Xiaoming Chen, Shaowei Ong
  • Patent number: 11850401
    Abstract: In one embodiment there is an injector comprising a housing having a proximal end and a distal end, a shell, a plunger, a needle guard, a first member, and an actuation assembly. The shell may be within the housing and may have a cavity to receive at least a portion of a medicament chamber. The shell may be moveable with respect to the housing from an initial position to an injecting position. The plunger may be moveable with respect to the shell. The needle guard may be moveable between an extended position and a retracted position. The first member may be within the housing. The actuation assembly may be coupled to the housing and the shell. The needle guard may move the first member with respect to the housing as the needle guard moves from the extended position to the retracted position. The actuation assembly may move the shell from the initial position to the injecting position when the first member moves with respect to the housing.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: December 26, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventors: Kevin Swanson, Aaron V. Hua
  • Patent number: 11844804
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: December 19, 2023
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Publication number: 20230390187
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Publication number: 20230372620
    Abstract: An injection device for injecting medicament in a patient comprises a housing configured to house a fluid reservoir that has one of a plurality of volumes of medicament. An injection conduit fluidly coupled to the fluid reservoir defines a fluid pathway from the fluid reservoir to the patient. A firing mechanism is coupled to the fluid reservoir and is configured to expel the medicament from the fluid reservoir through the injection conduit. A volume setting mechanism is coupled to the firing mechanism and is configured to select the one of the plurality of volumes of medicament for the firing mechanism to expel. A dose setting mechanism is configured to select all or a fraction of the one of the plurality of volumes of medicament that is injected from the injection conduit when the firing mechanism is actuated.
    Type: Application
    Filed: June 21, 2023
    Publication date: November 23, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Bryan James Sarkinen, Michael Travanty, Patrick Madsen, Andrew Charles Mork
  • Patent number: 11813435
    Abstract: An injector includes a trigger mechanism including: a trigger member disposed about an axis having an aperture and a protrusion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a trigger engagement member configured to engage the aperture of the trigger member when the trigger member is in a pre-firing condition; an energy source associated with the ram for powering the ram to expel the medicament; and a user-operable firing-initiation member having an aperture engaged with the protrusion of the trigger member and operable for causing an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: November 14, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventor: Michael Travanty
  • Patent number: 11771646
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: October 3, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Publication number: 20230302016
    Abstract: The present disclosure provides aqueous formulations comprising hydrocortisone sodium phosphate and monothioglycerol. In some embodiments, the formulations comprise monobasic sodium phosphate, dibasic sodium phosphate, or disodium EDTA. The present disclosure further provides a method of treating a disease or disorder in a subject by administering the aqueous formulation.
    Type: Application
    Filed: March 24, 2023
    Publication date: September 28, 2023
    Applicant: ANTARES PHARMA, INC.
    Inventors: Xiaoming Chen, Shaowei ONG
  • Publication number: 20230270950
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Application
    Filed: May 10, 2023
    Publication date: August 31, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter A. Hoeft, Paul R. Lesch, JR., Thomas E. Kramer
  • Patent number: 11717610
    Abstract: An injection device for injecting medicament in a patient comprises a housing configured to house a fluid reservoir that has one of a plurality of volumes of medicament. An injection conduit fluidly coupled to the fluid reservoir defines a fluid pathway from the fluid reservoir to the patient. A firing mechanism is coupled to the fluid reservoir and is configured to expel the medicament from the fluid reservoir through the injection conduit. A volume setting mechanism is coupled to the firing mechanism and is configured to select the one of the plurality of volumes of medicament for the firing mechanism to expel. A dose setting mechanism is configured to select all or a fraction of the one of the plurality of volumes of medicament that is injected from the injection conduit when the firing mechanism is actuated.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: August 8, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventors: Bryan James Sarkinen, Michael Travanty, Patrick Madsen, Andrew Charles Mork
  • Publication number: 20230211089
    Abstract: A dispensing mechanism for delivering a dosage of medicament including a housing, a push button, a crank arm that is slideably engageable with the push button, a ram, and a ratchet gear releasably engageable with the crank arm and ram, translation of the push button along an axis causing the crank arm to engage and rotate the ratchet gear which causes the ram to distally advance relative to the housing.
    Type: Application
    Filed: March 14, 2023
    Publication date: July 6, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Patrick Madsen, Hans Pflaumer, Kevin Swanson
  • Patent number: 11684723
    Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: June 27, 2023
    Assignee: Antares Pharma, Inc.
    Inventors: Julius C. Sund, Eric Lagman, Peter A. Hoeft, Paul R. Lesch, Jr., Thomas E. Kramer
  • Publication number: 20230191031
    Abstract: A jet injector that includes a prefilled syringe. The syringe includes a fluid chamber that contains a medicament. The syringe also has an injection-assisting needle, and a plunger is movable within the fluid chamber. A housing is configured for allowing insertion of the needle to a penetration depth. The housing includes a retractable guard and an interference component, e.g., a lock ring, adjacent to the retractable guard that interferes with the movement of the retractable guard. An energy source is configured for biasing the plunger to produce an injecting pressure to jet inject the medicament from the fluid chamber through the needle to an injection site.
    Type: Application
    Filed: February 15, 2023
    Publication date: June 22, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: James W. LANNAN, Julius C. SUND
  • Patent number: 11628260
    Abstract: A dispensing mechanism for delivering a dosage of medicament including a housing, a push button, a crank arm that is slideably engageable with the push button, a ram, and a ratchet gear releasably engageable with the crank arm and ram, translation of the push button along an axis causing the crank arm to engage and rotate the ratchet gear which causes the ram to distally advance relative to the housing.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: April 18, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventors: Patrick Madsen, Hans Pflaumer, Kevin Swanson